|
|
|
Name
|
CuraGen Corp. |
|
Address:
|
555 Long Wharf Dr.
|
|
City:
|
New Haven
|
|
State:
|
CT
|
|
Zip:
|
06511
|
|
Phone
|
203-401-3330
|
|
Web
Site:
|
www.curagen.com
|
|
Fax:
|
203-401-3331
|
|
No. Employees
|
350
|
|
No. Researchers
|
215
|
|
Capitalization
|
$230,070,000
|
|
R&D Spending
|
$72,700,000
|
|
Major Investors
|
Spears, Grisanti & Brown, LLC, Kopp Investment Advisors. Inc., Dimensional Fund Advisors Inc., Porter Orlan LLC, Cooper Hill Partners, L.L.C.,
|
|
Strategic Alliances
|
Abgenix, TopoTarget,
Bayer, Seattle Genetics
|
|
Products
|
Genomics-based pharmaceuticals
|
|
CFO
|
David M. Wurzer
|
|
Chief Scientific Research Officer
|
Timothy M. Shannon
|
|
Ownership
|
Public (NASDAQ: CRGN)
|
|
CEO
|
Jonathan M. Rothberg
|
|
Year Founded
|
1991
|
|
President
|
Jonathan M. Rothberg
|
|
|
|
|
|
|
|
Human Resource Manager/Director
|
Donna Starzecki
|
|
|
